Showing results (11-20 of 29) with videos related to
Sort By:
Pageof 3
Traffic (Copenhagen, Denmark)|March 29, 2011
A role for Rab7 in the movement of secretory granules in cytotoxic T lymphocytesTiziana Daniele, Yvonne Hackmann, Alex T Ritter, et al.Traffic (Copenhagen, Denmark)|March 12, 2002
The leaden gene product is required with Rab27a to recruit myosin Va to melanosomes in melanocytesAlistair N Hume, Lucy M Collinson, Colin R Hopkins, et al.Nature Immunology|October 21, 2003
Adaptor protein 3-dependent microtubule-mediated movement of lytic granules to the immunological synapseRichard H Clark, Jane C Stinchcombe, Anna Day, et al.Nature|March 29, 2002
A single motif responsible for ubiquitin recognition and monoubiquitination in endocytic proteinsSimona Polo, Sara Sigismund, Mario Faretta, et al.Nanoscale|September 17, 2021
Enhanced target-specific delivery of docetaxel-loaded nanoparticles using engineered T cell receptorsWilliam J McDaid, Nikolai Lissin, Ellen Pollheimer, et al.Traffic (Copenhagen, Denmark)|February 11, 2005
Normal lytic granule secretion by cytotoxic T lymphocytes deficient in BLOC-1, -2 and -3 and myosins Va, VIIa and XVGiovanna Bossi, Sarah Booth, Richard Clark, et al.Frontiers in Immunology|September 8, 2025
Cell-targeted PD-1 agonists are potent NK-cell inhibitorsHarriet C Pope, Ana L Chiodetti, Alice Newey, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|July 13, 2016
Elimination of Latently HIV-infected Cells from Antiretroviral Therapy-suppressed Subjects by Engineered Immune-mobilizing T-cell ReceptorsHongbing Yang, Sandrine Buisson, Giovanna Bossi, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 8, 2010
Ca2+ release from the endoplasmic reticulum of NY-ESO-1-specific T cells is modulated by the affinity of TCR and by the use of the CD8 coreceptorJi-Li Chen, Anthony J Morgan, Guillaume Stewart-Jones, et al.Scientific Reports|January 14, 2016
Direct molecular mimicry enables off-target cardiovascular toxicity by an enhanced affinity TCR designed for cancer immunotherapyMarine C C Raman, Pierre J Rizkallah, Ruth Simmons, et al.Pageof 3